Doron Sudarsky1,2, Merav Sudarsky2,3, Shlomi Matezky4,5, Ilan Goldenberg5,6, Ateret Farcas6, Eugenia Nikolsky2,7. 1. Heart Institute, Ha'Emek Medical Center, Afula. 2. Technion-Israel Institute of Technology, Haifa. 3. Clalit Health Services, Haifa and Western Galilee District. 4. Leviev Heart Center, the Sheba Medical Center at Tel Hashomer, Tel Aviv. 5. Tel Aviv University, Tel Aviv. 6. Neufeld Cardiac Research Institute, the Sheba Medical Center at Tel Hashomer, Tel Aviv. 7. Cardiology Department, Rambam Health Care Campus, Haifa, Israel.
Abstract
BACKGROUND: Anemia in patients with acute coronary syndromes (ACS) is strongly related to the increased risk of bleeding and mortality. Whether benefit of early invasive strategy exceeds the risk of bleeding in these patients is unknown. AIM: To assess impact of early coronary angiography on outcomes of patients with ACS and baseline anemia. METHODS AND RESULTS: Biennial Israeli ACS registry (ACSIS) prospectively collects data from all 26 public hospitals. The endpoints included rates of in-hospital major bleeding, as well as 30-day and 1-year mortality. Anemia at baseline was present in 1,464 of 5,600 patients with ACS (26.1%). Coronary angiography within index hospitalization was performed less frequently in patients with anemia (76.6% vs. 90.8%, P < 0.001). Non-performance of coronary angiography was associated with older age and higher prevalence of comorbidities. Among patients with anemia who underwent coronary angiography, the majority (95.5%) had obstructive coronary disease, of whom 77.8% were triaged to revascularization. Performance of coronary angiography was associated with significantly lower (P < 0.0001) rates of mortality at 30 days (5.7% vs. 15.6%) and at 1 year (11.9% vs. 34.1%). Major bleeding occurred with similar incidence in groups with and without coronary angiography (3.1% vs. 3.8%, respectively; P = 0.54). By multivariable analysis, performance of coronary angiography was an independent predictor of lower 1-year mortality (hazard ratio [95%CI] = 0.30 [0.21, 0.44]. CONCLUSION: In the setting of ACS, despite the presence of baseline anemia, early coronary angiography with subsequent revascularization, when indicated, was associated with improved clinical outcomes including 1-year mortality without significant increase in rates of major bleeding.
BACKGROUND:Anemia in patients with acute coronary syndromes (ACS) is strongly related to the increased risk of bleeding and mortality. Whether benefit of early invasive strategy exceeds the risk of bleeding in these patients is unknown. AIM: To assess impact of early coronary angiography on outcomes of patients with ACS and baseline anemia. METHODS AND RESULTS: Biennial Israeli ACS registry (ACSIS) prospectively collects data from all 26 public hospitals. The endpoints included rates of in-hospital major bleeding, as well as 30-day and 1-year mortality. Anemia at baseline was present in 1,464 of 5,600 patients with ACS (26.1%). Coronary angiography within index hospitalization was performed less frequently in patients with anemia (76.6% vs. 90.8%, P < 0.001). Non-performance of coronary angiography was associated with older age and higher prevalence of comorbidities. Among patients with anemia who underwent coronary angiography, the majority (95.5%) had obstructive coronary disease, of whom 77.8% were triaged to revascularization. Performance of coronary angiography was associated with significantly lower (P < 0.0001) rates of mortality at 30 days (5.7% vs. 15.6%) and at 1 year (11.9% vs. 34.1%). Major bleeding occurred with similar incidence in groups with and without coronary angiography (3.1% vs. 3.8%, respectively; P = 0.54). By multivariable analysis, performance of coronary angiography was an independent predictor of lower 1-year mortality (hazard ratio [95%CI] = 0.30 [0.21, 0.44]. CONCLUSION: In the setting of ACS, despite the presence of baseline anemia, early coronary angiography with subsequent revascularization, when indicated, was associated with improved clinical outcomes including 1-year mortality without significant increase in rates of major bleeding.
Authors: Mamas A Mamas; Chun Shing Kwok; Evangelos Kontopantelis; Anthony A Fryer; Iain Buchan; Max O Bachmann; M Justin Zaman; Phyo K Myint Journal: J Am Heart Assoc Date: 2016-11-19 Impact factor: 5.501
Authors: Ronald Huynh; Karice Hyun; Mario D'Souza; Nadarajah Kangaharan; Pratap C Shetty; Justin Mariani; Jens Kilian; Joseph Hung; Mark Ryan; Derek P Chew; David Brieger Journal: Clin Cardiol Date: 2019-06-19 Impact factor: 2.882
Authors: Faisal Alsayegh; Moh A Alkhamis; Fatima Ali; Sreeja Attur; Nicholas M Fountain-Jones; Mohammad Zubaid Journal: PLoS One Date: 2022-01-24 Impact factor: 3.240